Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB06097> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB06097 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06097 label "GSK-923295 [drugbank:DB06097]" assertion.
- drugbank:DB06097 seeAlso DB06097 assertion.
- drugbank:DB06097 description "GSK-923295 is a small-molecule inhibitor of the mitotic kinesin centromere-associated protein E (CENP-E), and the third novel drug candidate to arise from Cytokinetics' broad strategic alliance with GlaxoSmithKline (GSK). GSK-923295 demonstrated a broad spectrum of activity against a range of human tumor xenografts grown in nude mice, including models of colon, breast, ovarian, lung and other tumors. GSK-923295 is the first drug candidate to enter human clinical trials that specifically targets CENP-E and is currently in Phase I human clinical trials being conducted by GSK." assertion.
- drugbank:DB06097 identifier "drugbank:DB06097" assertion.
- drugbank:DB06097 title "GSK-923295" assertion.
- drugbank:DB06097 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB06097 drugbank_vocabulary:drugbank-id "DB06097" assertion.
- drugbank:DB06097 bio2rdf_vocabulary:x-identifiers.org DB06097 assertion.
- drugbank:DB06097 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06097" assertion.
- drugbank:DB06097 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06097 bio2rdf_vocabulary:identifier "DB06097" assertion.